We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

90 hedge funds and large institutions have $276M invested in Cardiovascular Systems, Inc. in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $808K | Put options by funds: $365K

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

2% more funds holding

Funds holding: 8890 (+2)

4% less capital invested

Capital invested by funds: $286M → $276M (-$10.2M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
90
Holders Change
+2
Holders Change %
+2.27%
% of All Funds
2.92%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
11
Increased
39
Reduced
24
Closed
8
Calls
$808K
Puts
$365K
Net Calls
+$443K
Net Calls Change
+$443K
Name Holding Trade Value Shares
Change
Change in
Stake
Massachusetts Financial Services
1
Massachusetts Financial Services
Massachusetts
$35.7M +$32.7K +1,570 +0.1%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$28.7M +$304K +14,610 +1%
First Manhattan
3
First Manhattan
New York
$23.2M
CCM
4
Consonance Capital Management
New York
$17.6M +$5.32M +255,353 +41%
MRM
5
Michael R. Murphy
$14.5M -$12.8K -617 -0.1%
BFA
6
BlackRock Fund Advisors
California
$11.8M +$1.37M +65,776 +13%
Vanguard Group
7
Vanguard Group
Pennsylvania
$11.4M +$638K +30,642 +6%
IIM
8
Ironwood Investment Management
Massachusetts
$11M +$290K +13,924 +3%
Wells Fargo
9
Wells Fargo
California
$10.4M +$4.08M +195,938 +61%
NCGI
10
Next Century Growth Investors
Minnesota
$9.71M +$3.67M +176,105 +57%
WA
11
Wasatch Advisors
Utah
$7.36M +$51K +2,450 +0.7%
State Street
12
State Street
Massachusetts
$6.4M +$501K +24,079 +8%
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$6.01M -$487K -23,398 -7%
Northern Trust
14
Northern Trust
Illinois
$6M +$341K +16,358 +6%
BIT
15
BlackRock Institutional Trust
California
$5.34M -$1.25M -59,842 -18%
WSA
16
Wall Street Associates
California
$5.24M -$54.1K -2,600 -1%
PCM
17
Perkins Capital Management
Minnesota
$4.67M -$1.11M -53,501 -19%
Allianz Asset Management
18
Allianz Asset Management
Germany
$4.37M +$504K +24,213 +13%
Millennium Management
19
Millennium Management
New York
$3.81M -$979K -47,042 -20%
EI
20
EAM Investors
California
$3.39M -$624K -29,967 -15%
EIM
21
Essex Investment Management
Massachusetts
$2.91M -$116K -5,567 -4%
SC
22
Sophrosyne Capital
New York
$2.64M -$933K -44,800 -25%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$2.6M +$366K +17,569 +16%
NC
24
Northpointe Capital
Michigan
$2.11M -$782K -37,560 -26%
DIA
25
Denver Investment Advisors
Colorado
$2.11M +$2.19M +105,120 New

CSII Hedge Fund Activity: Q3 2013 in Review

90 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2013, worth a combined $276M — down 3.6% from $286M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CSII positions and 8 closed out — a net gain of 3 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $5.32M. The largest seller was Castleark Management, exiting entirely with an estimated $3.35M sold.

  • 90 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2013, up from 88 in Q2 2013.
  • Funds reported $276M of Cardiovascular Systems, Inc. stock for Q3 2013, down 3.6% quarter-over-quarter.
  • 11 funds opened new Cardiovascular Systems, Inc. positions in Q3 2013 and 8 closed out, a net change of +3 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2013 was Consonance Capital Management, an estimated $5.32M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2013 was Castleark Management, an estimated $3.35M sold.

Based on aggregated 13F filings for Q3 2013.